Company: AMTX
Filing Date: 2025-05-08
Form Type: 10-Q
Source: 0001437749-25-015301
Chunk: 69

Company: AEMETIS, INC
Filing Date: 2025-05-08
Form: 10-Q
Item: Part I, Item 1F
Chunk 69
---
 of its Board of Directors. The following table summarizes activity under the
   2019 Stock Plan during the
   three-month period ending
    March 31, 2025:

    Shares Available for Grant    Number of Shares Outstanding    Weighted-Average Exercise Price  
 Balance as of December 31, 2024   78   7,201  $4.06 
 Authorized   2,148         
 Options Granted   (1,816)  1,816   2.73 
 RSAs Granted   (369)  -   - 
 Exercised   -   (51)  0.97 
 Forfeited/expired   62   (62)  4.87 
 Balance as of March 31, 2025   103   8,904  $3.80 

    The number of outstanding option shares as of
    March 31, 2025, includes
   5.5 million shares that are
    vested.

   Inducement Equity Plan

    In
    March 2016, the Board of Directors of the Company approved an Inducement Equity Plan authorizing the issuance of non-statutory options for the purchase of up 
   100,000 shares of common stock. This plan was
   not approved by stockholders and as a result is available only for grants to prospective employees. As of
    March 31, 2025, there are
   no option grants outstanding under the Inducement Equity Plan.

    15

     (Tabular data in thousands, except par value and per share data)

   Stock-based Compensation Expense

    Stock-based compensation is accounted for in accordance with
   ASC 718, Compensation - Stock Compensation, which requires the measurement and recognition of compensation expense for all stock-based awards made to employees, directors, and consultants based on estimated fair value on the grant date. We estimate the fair value using the Black-Scholes option pricing model and recognize that fair value as an expense over the vesting period of each grant using the straight-line method. We only record compensation cost for vested options. The Black-Scholes valuation model for stock-based compensation expense requires us to make assumptions and judgments about the variables used in the calculation, including the expected term (the period of time that the options granted are expected to be outstanding), the volatility of our common stock